41 results on '"de Matos Guedes, Herbert Leonel"'
Search Results
2. NKG2C+CD57+ natural killer cells with senescent features are induced during cutaneous leishmaniasis and accumulate in patients with lesional healing impairment.
3. Anti-Leishmania Effects of Volatile Oils and Their Isolates
4. B-1 lymphocytes are able to produce IL-10, but is not pathogenic during Leishmania (Leishmania) amazonensis infection
5. The role of Toll-like receptor 9 in a murine model of Cryptococcus gattii infection
6. Leishmanicidal therapy targeted to parasite proteases
7. Combined therapy with adipose tissue-derived mesenchymal stromal cells and meglumine antimoniate controls lesion development and parasite load in murine cutaneous leishmaniasis caused by Leishmania amazonensis
8. The role of the P2X7 receptor in murine cutaneous leishmaniasis: aspects of inflammation and parasite control
9. Pulmonary Fibrosis and Hypereosinophilia in TLR9-/- Mice Infected by Cryptococcus gattii
10. Intradermal Immunization of SARS-CoV-2 Original Strain Trimeric Spike Protein Associated to CpG and AddaS03 Adjuvants, but Not MPL, Provide Strong Humoral and Cellular Response in Mice
11. Immunogenicity of SARS-CoV-2 Trimeric Spike Protein Associated to Poly(I:C) Plus Alum
12. Simvastatin Resistance of Leishmania amazonensis Induces Sterol Remodeling and Cross-Resistance to Sterol Pathway and Serine Protease Inhibitors
13. SARS-CoV-2 Is Persistent in Placenta and Causes Macroscopic, Histopathological, and Ultrastructural Changes.
14. MPLA and AddaVax® Adjuvants Fail to Promote Intramuscular LaAg Vaccine Protectiveness against Experimental Cutaneous Leishmaniasis
15. PD-1 Blockade Modulates Functional Activities of Exhausted-Like T Cell in Patients With Cutaneous Leishmaniasis
16. PF-429242, a Subtilisin Inhibitor, Is Effective in vitro Against Leishmania infantum
17. Oligopeptidase B from Leishmania amazonensis: molecular cloning, gene expression analysis and molecular model
18. Protection against cutaneous leishmaniasis by intranasal vaccination with lipophosphoglycan
19. Peripheral expression of LACK-mRNA induced by intranasal vaccination with PCI-NEO-LACK defines the protection duration against murine visceral leishmaniasis
20. Intranasal immunization with LACK-DNA promotes protective immunity in hamsters challenged with Leishmania chagasi
21. Vitamin D increases killing of intracellular Leishmania amazonensis in vitro independently of macrophage oxidative mechanisms
22. How to B(e)-1 Important Cell During Leishmania Infection
23. ELISA for early diagnosis of histoplasmosis
24. Nanoencapsulated retinoic acid as a safe tolerogenic adjuvant for intranasal vaccination against cutaneous leishmaniasis
25. Characterization of Sv129 Mice as a Susceptible Model to Leishmania amazonensis
26. Dietary Vitamin D3 Deficiency Increases Resistance to Leishmania (Leishmania) amazonensis Infection in Mice
27. The role of TLR9 on Leishmania amazonensis infection and its influence on intranasal LaAg vaccine efficacy
28. Immunomodulating role of IL-10-producing B cells in Leishmania amazonensis infection
29. Anti-LeishmaniaEffects of Volatile Oils and Their Isolates
30. Effects of Bone Marrow Mesenchymal Stromal Cell Therapy in Experimental Cutaneous Leishmaniasis in BALB/c Mice Induced by Leishmania amazonensis
31. The role of the P2X7 receptor in murine cutaneous leishmaniasis: aspects of inflammation and parasite control
32. Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl/6 mice
33. Diet-induced obesity promotes systemic inflammation and increased susceptibility to murine visceral leishmaniasis
34. Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl/6 mice.
35. Intranasal immunization with LACK-DNA promotes protective immunity in hamsters challenged withLeishmania chagasi
36. Serine proteases of Leishmania amazonensis as immunomodulatory and disease-aggravating components of the crude LaAg vaccine
37. Intranasal vaccination with extracellular serine proteases of Leishmania amazonensis confers protective immunity to BALB/c mice against infection.
38. Binding of extracellular matrix proteins to Paracoccidioides brasiliensis
39. MPLA and AddaVax ® Adjuvants Fail to Promote Intramuscular LaAg Vaccine Protectiveness against Experimental Cutaneous Leishmaniasis.
40. Intranasal vaccination with killed Leishmania amazonensis promastigotes antigen (LaAg) associated with CAF01 adjuvant induces partial protection in BALB/c mice challenged with Leishmania (infantum) chagasi.
41. The Comparative Genomics and Phylogenomics of Leishmania amazonensis Parasite.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.